Like Medimix International

announced 5/30/2019 via BusinessWire

Evidera, will acquire Medimix International

See 710 Comparable Transactions
synopsis: Evidera, a business unit of PPD, LLC, and a provider of evidence-based solutions demonstrating the real-world effectiveness and safety of health care products, will acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries.
buyer parent: Carlyle Group
buyer: Evidera
Evidera, a PPD business unit, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of health care products. They help biopharmaceutical, biotechnology and medical device companies generate the evidence needed to optimize the market access. "
 target: Medimix International
Medimix International specializes in providing business understanding, real-world evidence insights to the pharmaceutical and medical device industries. Medimix’s primary solution, LiveTracker™, is a cloud-based platform that provides real-time monitoring of clients’ particular therapeutic markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2014 via PR Newswire

Decision Resources Group, acquired Relay Technology Management

See 223 Comparable Transactions
synopsis: Piramal Enterprises' Information Management Subsidiary, Decision Resources Group, one of the world's leading research and advisory firms focusing on high-value healthcare insights and analytics, announced that it acquired Relay Technology Management, a data analytics company focused on the life-sciences industry.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
 target: Relay Technology Management
Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief: that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/13/2019 via BusinessWire

Saama Technologies, will acquire Comprehend Systems, Inc.

See 207 Comparable Transactions
synopsis: Saama Technologies, Inc., the advanced clinical data and analytics company, announced that it has signed a definitive agreement to acquire Comprehend Systems, Inc., a company that provides a suite of cloud applications and consulting services that dramatically improve the clinical trial process.
buyer: Saama Technologies
Saama Technologies is the advanced clinical data and analytics company, unleashing wisdom from data to deliver better actionable business outcomes for the life sciences industry. "
 target: Comprehend Systems, Inc.
Comprehend provides a suite of cloud applications and consulting services that dramatically improve the clinical trial process. Their solutions deliver actionable risk and performance insights across studies, systems, sites, and vendors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/15/2016 via PR Newswire

The WIRB-Copernicus Group, will purchase Clinical Trial Applications from karmadata

See 154 Comparable Transactions
synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality of clinical research, will acquire from karmadata a suite of proprietary applications designed to facilitate the management of clinical trial data. karmadata is the market leader in clinical trial database and decision support applications.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
 seller: karmadata
Karmadata is able to standardize and link the world's healthcare data ranging from leading open data sources to priva pharmacy and medical claims. Its propriety applications are designed to facilitate the management of clinical trial data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/6/2015 via BusinessWire

IMS Health Incorporated, acquired Dataline Software

See 103 Comparable Transactions
synopsis: IMS Health has acquired Dataline Software, a leader in Big Data analytics for healthcare. U.K.-based Dataline has worked closely with life sciences companies, payers, healthcare authorities and academia to deliver tailored software for rapid analysis and elegant visualizations of large, complex healthcare data sets.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is an information and technology services company providing clients in the healthcare industry with solutions to measure and improve their performance. The company's IMS One™ cloud platform provides comprehensive insights into diseases, treatments, costs and outcomes. "
 target: Dataline Software
Dataline is a software solutions company specializing in big-data analytics solutions for healthcare. They also provide consultancy, training, system implementation, application development and technical support to a wide and varied client base.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2014 via Company Press Release

ERT, acquired eClinical Insights, Inc.

See 207 Comparable Transactions
synopsis: ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, announced the acquisition of eClinical Insights (eCI), an innovative provider of cloud-based clinical trials management software.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data. "
 target: eClinical Insights, Inc.
eClinical Insights® is a leading-edge provider of cloud-based clinical software that provides clinical research professionals with the strategic visibility to make rapid, data-driven decisions to positively impact the performance and cost of their clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/24/2009 via PR Newswire

OmniComm Systems, Inc., purchased EDC Solutions from eResearch Technology, Inc.

See 207 Comparable Transactions
synopsis: OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, has acquired the EDC business of eResearchTechnology, Inc., a global provider of technology and services that enable life science industries worldwide to collect, interpret, and distribute cardiac safety and clinical data.
buyer: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm Systems, Inc. provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. "
 seller: eResearch Technology, Inc.
eResearchTechnology, Inc. (eRT) is a provider of technology-based products and services that enable the pharmaceutical, biotechnological, medical device, and contract resource companies to collect, interpret, and distribute cardiac safety and clinical data more efficiently.
price ($mm)[EV]
$2.02 [$0.87]
rev ($mm)
$6
EBITDA ($mm)
EV / rev
0.1x
EV / EBITDA
closed 7/15/2009 via BusinessWire

Merge Healthcare, acquired etrials, Inc.

See 207 Comparable Transactions
synopsis: Merge Healthcare Inc., a leading health IT solutions provider, and etrials Worldwide, Inc., a leading provider of clinical trials software and services, announced the expiration of the exchange offer for the shares of etrials’ common stock by Merge Acquisition Corp. Merge now owns approximately 86% of the outstanding shares of Etrials common stock.
buyer: Merge Healthcare (MRGE:$227.59)
Merge Healthcare Incorporated builds software solutions that automate healthcare data and diagnostic workflow to build a better electronic record of the patient experience. "
 target: etrials, Inc.
etrials has earned the loyalty of its healthcare partners by guiding them to simplify and accelerate the processes associated with collecting data in clinical trials. Using innovative technologies and proven business processes, etrials offers the most efficient data management products and services.
price ($mm)[EV]
$21 [$14]
rev ($mm)
$16
EBITDA ($mm)
EV / rev
0.9x
EV / EBITDA
closed 8/15/2013 via Company Press Release

Litéra Corp, purchased AxxiTRIALS from Axxiem Web Solutions

See 209 Comparable Transactions
synopsis: Litera has announced the acquisition of AxxiTRIALS from Axxiem Web Solutions. AxxiTRIALS is a leading Clinical Trials Portal solution providing life science companies and clinical research organizations (CROs) with a platform designed to dramatically speed site start-up, patient recruitment, and end-to-end clinical trial operations.
buyer: Litéra Corp
Litéra Corp. engages in developing and marketing content lifecycle management solutions for law firms and corporations worldwide. It offers document creation, comparison, collaboration, and cleansing software solutions that manage documents throughout their lifecycle. "
 seller: Axxiem Web Solutions
AxxiTRIALS developed by Axxiem is a web-based clinical trials communication portal. AxxiTRIALS provides a simple and secure way to efficiently distribute and track time-sensitive documents and training materials to users around the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/25/2008 via BusinessWire

Bio-Imaging Technologies, Inc., acquired Phoenix Data Systems Inc.

See 209 Comparable Transactions
synopsis: Bio-Imaging Technologies, Inc. it has acquired privately held Phoenix Data Systems, Inc., a leading global clinical data services provider of electronic data capture services and a comprehensive array of broadly interoperable eClinical data solutions to the pharmaceutical and biotechnology industries.
buyer: Bio-Imaging Technologies, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
 target: Phoenix Data Systems Inc.
Phoenix Data Systems delivers Full Service EDC, a unique combination of electronic data capture, interactive voice response, reporting, and data management services that give clinical data managers improved control to run well-managed studies.
price ($mm)[EV]
$19 [$18]
rev ($mm)
$12
EBITDA ($mm)
$1
EV / rev
1.8x
EV / EBITDA
15.4x
closed 11/25/2020 via Company Press Release

Advarra, acquired Longboat Clinical Ltd.

See 284 Comparable Transactions
synopsis: Advarra, the market leader in regulatory review solutions and clinical site technologies, is pleased to announce the acquisition of Longboat, an innovative provider of clinical trial technologies focused on site training, protocol compliance, and patient engagement.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
 target: Longboat Clinical Ltd.
Longboat is an innovative provider of user-friendly, fully mobile clinical research technology solutions that take the complexity out of trials for site staff, patients, monitors, and study teams, making protocol compliance easy and instinctive.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/11/2020 via BNC Analysis

A Consortium of 4 Buyers acquired Envision Pharma Group

See 1041 Comparable Transactions
synopsis: GHO Capital, together with Mubadala Investment Company, the Abu Dhabi-based sovereign investor, and including HarbourVest Partners and Northwestern Mutual, acquired the majority stake in Envision from Ardian SAS, a Paris-based global buyout firm. Envision Pharma Group is a global technology and scientific communications.
buyer: Mubadala Investment Company
buyer: HarbourVest Partners, LLC
buyer: GHO Capital
buyer: Northwestern Mutual
GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. Mubadala is a pioneering global investor. HarbourVest is an independent, global private markets asset manager. Northwestern Mutual helps families and businesses achieve financial security. "
 target parent: Ardian
target: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/2/2020 via Company Press Release

Cytel Inc., acquired Laiya Consulting, Inc.

See 268 Comparable Transactions
synopsis: Cytel Inc. has announced the acquisition of Laiya Consulting, a drug development solutions company specializing in Bayesian adaptive trial designs and implementation. Laiya pioneered the delivery of trial design software using SaaS, which aligns with Cytel’s goal of making all of its design software available as a cloud-based service.
buyer parent: New Mountain Capital, LLC
buyer: Cytel Inc.
Cytel provides statistical software for clinical trials. Cytel provides an understanding of software tools that solve statistical problems and that meet the highest standards of reliability, technical documentation and customer support. "
 target: Laiya Consulting, Inc.
Founded in 2010, Laiya Consulting has supported drug developers to drive success rates and maximize portfolio returns through the design and implementation of Bayesian adaptive trials, robust clinical strategies, and integrated software platforms.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/13/2016 via PE Hub

Ardian, GHO Capital, acquired Envision Pharma, Inc.

See 1041 Comparable Transactions
synopsis: Leading middle-market private equity firm, The Halifax Group, announced that it has sold Envision Pharma Group to Ardian and GHO Capital. Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
buyer: Ardian
buyer: GHO Capital
Ardian is an independent private investment company with assets of US$55bn managed or advised in Europe, North America and Asia. Global Healthcare Opportunities, or GHO Capital, was founded in 2014 as a specialist healthcare investment adviser based in London. "
 target parent: Halifax Group
target: Envision Pharma, Inc.
Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/19/2013 via BusinessWire

Halifax Group, acquired Envision Pharma, Inc.

See 1041 Comparable Transactions
synopsis: The Halifax Group, a leading middle-market private equity firm, announced that it has acquired Envision Pharma, Inc. from a subsidiary of Express Scripts Holding Co. Envision is an innovative global technology and scientific communication company focused on the pharmaceutical, biotechnology and medical device industries.
buyer: Halifax Group
The Halifax Group is a private equity firm that invests between $10 and $40 million alongside owners and managers of established, growing and profitable companies that are leaders in their market niche. "
 target parent: Express Scripts Inc.
target: Envision Pharma, Inc.
Envision Pharma, founded in 2001, is an innovative global technology and scientific communication company serving pharmaceutical, biotechnology and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/15/2021 via PR Newswire

Veeva Systems, acquired Veracity Logic

See 252 Comparable Transactions
synopsis: Veeva Systems, the global leader in cloud software for the life sciences industry, has acquired Veracity Logic, a provider of cloud software for randomization and trial supply management (RTSM). Veracity Logic provides a robust, reliable, and user-friendly RTSM solution designed to simplify complex processes and expedite clinical trials.
buyer: Veeva Systems (VEEV:$1,762.04)
Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 775 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. "
 target: Veracity Logic
Veracity Logic is a provider of cloud software for randomization and trial supply management (RTSM). Veracity Logic's RTSM solution simplifies complex processes and expedites clinical trials. Their software covers a range of trial designs in pharma/biotech, medical device, and diagnostics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/30/2021 via BNC Analysis

CSAM Health AS, acquired MedSciNet

See 236 Comparable Transactions
synopsis: CSAM Health Group AS, the leading provider of niche eHealth solutions in the Nordics, announced that they have acquired MedSciNet AB, a provider of benchmark eHealth solutions within clinical research.
buyer: CSAM Health AS (OB:CSAM:$34.31)
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. "
 target: MedSciNet
MedSciNet is a Stockholm based company specialising in design and development of web applications and on-line database systems for clinical trials and studies, quality registries, medical bio-banks, and other solutions within the medical field.
price ($mm)
$2.88
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
announced 5/27/2021 via PR Newswire

Thoma Bravo, LLC, will acquire Greenphire, Inc

See 242 Comparable Transactions
synopsis: Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.
buyer: Thoma Bravo, LLC
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make acquisitions intended to accelerate revenue and earnings. "
 target parent: The Riverside Company
target: Greenphire, Inc
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2021 via GlobeNewswire

Scarritt Group Inc., acquired TrialTech Medical Inc.

See 310 Comparable Transactions
synopsis: Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, has acquired TrialTech Medical Inc, a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials.
buyer: Scarritt Group Inc.
Scarritt Group is a technology-enabled, full service meeting planning and logistics company specializing in delivering clinical trial meetings worldwide. "
 target: TrialTech Medical Inc.
TrialTech Medical is a software and services company supporting the pharmaceutical, biotechnology and medical device industries. They work in coordination with their clients' medical and clinical operations teams to optimize the process of clinical trial planning, recruitment and enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

See 240 Comparable Transactions
synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
 target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  
announced 5/30/2019 via BusinessWire

Evidera, will acquire Medimix International

See 710 Comparable Transactions
synopsis: Evidera, a business unit of PPD, LLC, and a provider of evidence-based solutions demonstrating the real-world effectiveness and safety of health care products, will acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries.
buyer parent: Carlyle Group
buyer: Evidera
Evidera, a PPD business unit, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of health care products. They help biopharmaceutical, biotechnology and medical device companies generate the evidence needed to optimize the market access. "
 target: Medimix International
Medimix International specializes in providing business understanding, real-world evidence insights to the pharmaceutical and medical device industries. Medimix’s primary solution, LiveTracker™, is a cloud-based platform that provides real-time monitoring of clients’ particular therapeutic markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/30/2019 via BusinessWire

Evidera, will acquire Medimix International

See 710 Comparable Transactions
synopsis: Evidera, a business unit of PPD, LLC, and a provider of evidence-based solutions demonstrating the real-world effectiveness and safety of health care products, will acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries.
buyer parent: Carlyle Group
buyer: Evidera
Evidera, a PPD business unit, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of health care products. They help biopharmaceutical, biotechnology and medical device companies generate the evidence needed to optimize the market access. "
 target: Medimix International
Medimix International specializes in providing business understanding, real-world evidence insights to the pharmaceutical and medical device industries. Medimix’s primary solution, LiveTracker™, is a cloud-based platform that provides real-time monitoring of clients’ particular therapeutic markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2014 via PR Newswire

Evidera, acquired Archimedes, Inc.

See 227 Comparable Transactions
synopsis: Symphony Technology Group (STG), a technology and services-focused private equity firm, and Evidera, a leading provider of evidence-based solutions for the healthcare industry, announced the acquisition of Archimedes, a San Francisco-based healthcare modeling company and wholly owned subsidiary of Kaiser Permanente.
buyer parent: Symphony Technology Group
buyer: Evidera
Evidera provides health economics, outcomes research, market access, data analytics and epidemiology services. Their research and consulting services are driven by world-class science and thought leadership and leverage a unique combination of capabilities. "
 target parent: Kaiser Permanente
target: Archimedes, Inc.
Archimedes is a healthcare modeling and analytics organization. With the Archimedes Model at its core, the company enables people to combine real-world healthcare data and simulation data to create compelling and actionable evidence used in individual healthcare decision making.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/26/2020 via PR Newswire

Arsenal Capital Partners, acquired BresMed Health Solutions Ltd

See 228 Comparable Transactions
synopsis: Arsenal Capital Partners, a leading private equity firm investing in healthcare and specialty industrials companies, announced the acquisition of BresMed Health Solutions, a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry.
buyer: Arsenal Capital Partners
Arsenal is a leading private equity firm that specializes in investments in middle‐market specialty industrials and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds of $5.3 billion, and completed more than 45 platform investments. "
 target: BresMed Health Solutions Ltd
BresMed is a health economic and outcomes research consultancy that provides health economic solutions to the global pharmaceutical industry. Established in 2006, BresMed has more than 150 staff across offices in the U.K., Ireland, the Netherlands, the U.S., and India.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/22/2020 via PR Newswire

Clarivate Analytics, will acquire Decision Resources Group

See 119 Comparable Transactions
synopsis: Clarivate Analytics plc, a global leader in providing trusted insights and analytics, will acquire Decision Resources Group ("DRG"), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited, part of global business conglomerate Piramal Group.
buyer: Clarivate Analytics (:$1,614.03)
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management. "
 target parent: Piramal Group
target: Decision Resources Group
Decision Resources Group (DRG) is uniquely positioned to help healthcare businesses improve the lives of patients around the world by creating patient-centric commercial strategies that drive better outcomes and better access.
price ($mm)
$950
rev ($mm)
$207
EBITDA ($mm)
$48
EV / rev
4.6x
EV / EBITDA
20.0x
closed 12/11/2019 via PR Newswire

Corrona, Inc., acquired HealthiVibe LLC

See 100 Comparable Transactions
synopsis: Corrona, LLC, a leading provider of real-world observational and syndicated registry data, announced that it has acquired HealthiVibe, LLC, a leading patient experience company. HealthiVibe uses a systematic, evidence-based process to help pharmaceutical clients spearhead patient engagement initiatives of the product lifecycle.
buyer parent: Great Point Partners
buyer: Corrona, Inc.
Corrona provides real world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators. "
 target: HealthiVibe LLC
HealthiVibe uses a systematic, evidence-based process to help pharmaceutical clients spearhead patient engagement initiatives of the product lifecycle. They leverage models and online analytic platforms to provide tools to optimize clinical trials and enhance product commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/30/2019 via Company Press Release

Eversana, will acquire Cornerstone Research Group

See 116 Comparable Transactions
synopsis: EVERSANA™, the leading independent provider of commercial services to the life science industry, announced an agreement to acquire Canada-based Cornerstone Research Group, Inc. Cornerstone is a global health economic and market access research company supporting pharmaceutical and medical device companies.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
 target: Cornerstone Research Group
Cornerstone is a global health economic and market access research company supporting pharmaceutical and medical device companies. Founded in 2005, Cornerstone’s initial focus was to build on the partners’ experience in health economic research with an emphasis on global cost-effectiveness models.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/7/2018 via BNC Analysis

Ancor Capital Partners, acquired STATinMed

See 24 Comparable Transactions
synopsis: Ancor Capital Partners, a Dallas-based private equity firm, announces the acquisition of STATinMED Research, a leading medical technology company in the health economics and outcomes research industry. STATinMED provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies.
buyer: Ancor Capital Partners
Ancor Capital Partners is an operations-oriented private equity firm focused on lower middle-market companies with EBITDA of $5-$15 million. Extensive operational experience gives the Ancor team a unique understanding of the critical business issues faced by lower middle-market companies. "
 target: STATinMed
STATinMED Research provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies. All STATinMED Research consultants hold academic positions with prestigious universities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/2/2017 via BNC Analysis

RWS Holdings plc, acquired Article One Partners, LLC

See 2 Comparable Transactions
synopsis: RWS Holdings, the world's leading provider of intellectual property support services, has acquired Article One Partners, the world’s largest patent research community. Article One Partners broadcasts its studies to over 40,000 people and distributes more than $7.8 million in rewards to researchers for their work on over 5,600 client patent studies.
buyer: RWS Holdings plc (AIM:RWS:$915.91)
RWS Holdings provides intellectual property support services such as patent translations and technical searches for clients in the medical, pharmaceutical, chemical, aerospace, and telecommunications industries. "
 target: Article One Partners, LLC
Article One Partners (AOP) is the world’s largest patent research community, broadcasting its studies to over 40,000 people. The company is a partner to 17 Fortune 100 companies, 74 Forbes Global 2000 and 7 of the top 10 US patent filers.
price ($mm)
$8.00
rev ($mm)
$4
EBITDA ($mm)
EV / rev
2.2x
EV / EBITDA
closed 8/16/2017 via PR Newswire

Decision Resources Group, acquired Context Matters

See 109 Comparable Transactions
synopsis: Decision Resources Group announced that it has completed the acquisition of Context Matters, the innovative data technology start-up that developed a first-of-its-kind global market access integrated data platform.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
 target: Context Matters
Context Matters is led by a team with extensive experience in the pharma & biotech and financial & information sectors with deep operational familiarity of the issues facing the pharmaceutical industry and those following the industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via GlobeNewswire

Aptean, acquired GQ Life Sciences, Inc

See 13 Comparable Transactions
synopsis: Aptean, a leading provider of mission critical enterprise software solutions that help 6,500 organizations stay at the forefront of their industries, announced the acquisition of GQ Life Sciences, Inc., a global provider of life science patent search solutions including SaaS-based search capabilities.
buyer parent: Vista Equity Partners
buyer: Aptean
Aptean is a leading provider of mission critical enterprise software solutions. Their solutions help nearly 5,000 organizations stay at the forefront of their industries by enabling them to operate more efficiently, thereby ensuring higher customer satisfaction. "
 target parent: Milestone Venture Partners
target: GQ Life Sciences, Inc
GQ Life Sciences, Inc. is a global life science information and search company and the market leader in biological sequence comparison. GQ Life Sciences is proud to offer its second major product, LifeQuest, alongside its flagship GenomeQuest software.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/22/2016 via PR Newswire

The WIRB-Copernicus Group, acquired CenterWatch, Inc.

See 164 Comparable Transactions
synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, announced its acquisition of CenterWatch, the leading provider of clinical trial industry news and information. CenterWatch provides clinical trials information to clinical research professionals.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
 target: CenterWatch, Inc.
CenterWatch is the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from sponsors and CROs, to investigative sites, technology solutions and niche providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/11/2016 via BusinessWire

WNS Global Services, will acquire Value Edge Research Services

See 255 Comparable Transactions
synopsis: WNS, a leading provider of global Business Process Management services, announced that the company entered into a definitive agreement to acquire Value Edge Research Services Pvt. Ltd., a leading provider of commercial research and analytics services to clients in the Pharma/Biopharma industry.
buyer: WNS Global Services (WNS:$585.82)
WNS is a leading global business process management company. WNS offers business value to 200+ global clients by combining operational excellence with deep domain expertise in key industry verticals including Travel, Banking and Financial Services, Manufacturing, Retail and Consumer Packaged Goods. "
 target: Value Edge Research Services
Value Edge provides consulting grade marketing and data analytics to a blue-chip roster of globally leading bio-pharma companies. Value Edge has created a cloud-based advanced technology platform designed to provide clients with competitive intelligence (CI) to drive strategic decision-making.
price ($mm)
$18
rev ($mm)
$5
EBITDA ($mm)
EV / rev
3.5x
EV / EBITDA
announced 3/11/2016 via BusinessWire

WNS Global Services, will acquire Value Edge Research Services

See 255 Comparable Transactions
synopsis: WNS, a leading provider of global Business Process Management services, announced that the company entered into a definitive agreement to acquire Value Edge Research Services Pvt. Ltd., a leading provider of commercial research and analytics services to clients in the Pharma/Biopharma industry.
buyer: WNS Global Services (WNS:$585.82)
WNS is a leading global business process management company. WNS offers business value to 200+ global clients by combining operational excellence with deep domain expertise in key industry verticals including Travel, Banking and Financial Services, Manufacturing, Retail and Consumer Packaged Goods. "
 target: Value Edge Research Services
Value Edge provides consulting grade marketing and data analytics to a blue-chip roster of globally leading bio-pharma companies. Value Edge has created a cloud-based advanced technology platform designed to provide clients with competitive intelligence (CI) to drive strategic decision-making.
price ($mm)
$18
rev ($mm)
$5
EBITDA ($mm)
EV / rev
3.5x
EV / EBITDA
announced 3/8/2016 via PR Newswire

Nordic Capital, will acquire ERT

See 61 Comparable Transactions
synopsis: Genstar Capital, a leading private equity firm focused on the healthcare, software, financial services, and industrial technology industries, announced the sale of ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, to Nordic Capital Fund VIII.
buyer: Nordic Capital
Nordic Capital is a leader in Nordic private equity investments, and now has an enviable reputation in investment and portfolio management. Since launching in 1989, Nordic Capital funds have delivered outstanding returns for our investors. "
 target parent: Genstar Capital LLC
target: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions.
price ($mm)
rev ($mm)
$300
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 11/4/2015 via PR Newswire

Precision for Value, acquired Redwood Outcomes

See 122 Comparable Transactions
synopsis: Precision for Value, a company that supports commercial excellence for global pharmaceutical and life sciences clients through the demonstration and communication of product value and outcomes, announced its acquisition of Redwood Outcomes, a leading international health economics and outcomes research company.
buyer parent: Precision for Medicine
buyer: Precision for Value
Precision for Value supports excellence for global pharmaceutical and life sciences clients through the communication of product value and outcomes. The Precision for Value teams provide clients with services of industry knowledge, demonstrated analytics proficiency, and communications prowess. "
 target: Redwood Outcomes
Redwood Outcomes is a Health Economics & Outcomes Research firm. They aim to advance and apply the science of evidence synthesis, integration, and communication to optimize health care decision-making.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

See 89 Comparable Transactions
synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
 target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 6/16/2015 via PR Newswire

Schulman Associates Institutional Review Board, acquired Absolute Research

See 4 Comparable Transactions
synopsis: Schulman Associates IRB, Inc., a customer service and technology company, has acquired Absolute Research. Absolute Research provides protection for human subjects involved in research while supporting a research enterprise. Absolute Research allows research administrators to navigate obstacles for biomedical and social-behavioral research.
buyer: Schulman Associates Institutional Review Board
Schulman Associates IRB is a leader in the protection of human research participants that offers IRB review services to clinical trial sponsors, CROs, and institutions. Schulman offers consulting services that improve clinical studies, data integrity and the protection of human subjects. "
 target: Absolute Research
AbsoluteResearch accesses information to advise investigators on regulatory issues and make decisions for an IRB office. Their tools use experiences in IRB Management as well as Bioethics and with their Web-Based Solution they enable Research Institutes to analyze guidance from regulatory agencies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

See 56 Comparable Transactions
synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
 target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

See 94 Comparable Transactions
synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
 target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/3/2012 via PR Newswire

Genstar Capital LLC, acquired ERT

See 61 Comparable Transactions
synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations, announced that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction.
buyer: Genstar Capital LLC
Genstar Capital LLC has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, software and software services, insurance and financial services, and industrial technology industries. "
 target: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives.
price ($mm)[EV]
$395 [$370]
rev ($mm)
$194
EBITDA ($mm)
$42
EV / rev
1.9x
EV / EBITDA
9.0x
closed 3/6/2012 via Company Press Release

GfK Group, acquired Bridgehead International

See 68 Comparable Transactions
synopsis: GfK, one of the world’s largest market research organizations, announced the full acquisition and integration of Bridgehead International – operating henceforth as GfK Bridgehead – a leading market access consultancy serving global companies in the pharmaceutical, medical device and diagnostics industries.
buyer: GfK Group (XTRA:GFK:$1,759.04)
GfK is one of the world’s largest research companies, with more than 11,000 experts working to discover new insights into the way people live, think and shop, in over 100 markets, every day. "
 target: Bridgehead International
Bridgehead International is globally recognized for its expertise in market access strategy; pricing and reimbursement strategy; health economics and health technology assessment.
price ($mm)
rev ($mm)
$16
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 1/19/2011 via Company Press Release

ICON Plc, acquired Oxford Outcomes

See 115 Comparable Transactions
synopsis: ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced the expansion of its Late Phase and Outcomes Research services through the acquisition of Oxford Outcomes, a leading international health outcomes consultancy.
buyer: ICON Plc (ICLR:$1,541.91)
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. "
 target: Oxford Outcomes
Headquartered in Oxford, UK, and with offices in the USA and Canada, Oxford Outcomes provides specialist services in the areas of patient reported outcomes (PRO), health economics, epidemiology and translation and linguistic validation.
price ($mm)
$28*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  

Like Medimix International


read more

Medimix International

Relay Technology Management

Comprehend Systems, Inc.

karmadata

Dataline Software

eClinical Insights, Inc.

eResearch Technology, Inc.

etrials, Inc.

Axxiem Web Solutions

Phoenix Data Systems Inc.

Longboat Clinical Ltd.

Envision Pharma Group

Laiya Consulting, Inc.

Envision Pharma, Inc.

Envision Pharma, Inc.

Veracity Logic

MedSciNet

Greenphire, Inc

TrialTech Medical Inc.

Viedoc

Pages:  
read more

Medimix International

read more

Medimix International

Archimedes, Inc.

read more

BresMed Health Solutions Ltd

Decision Resources Group

HealthiVibe LLC

Cornerstone Research Group

STATinMed

Article One Partners, LLC

Context Matters

GQ Life Sciences, Inc

CenterWatch, Inc.

Value Edge Research Services

Value Edge Research Services

ERT

Redwood Outcomes

Avalere Health LLC

Absolute Research

Abacus International

Decision Resources Group

ERT

Bridgehead International

Oxford Outcomes

Pages:  
Geography
Matching Companies
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: OTCPK:IGMB.D
 
 
 
 
 
 
 
 
Clinigence, LLC.
Clinigence Holdings, a fully reporting, publicly-held company, is a leading healthcare information technology company providing an advanced, cloud-based platform that enables healthcare organizations to provide value-based care and population health management.
year
2018
rev ($mm)
$1.37
EBITDA ($mm)
($0.84)
EBIT ($mm)
($0.84)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: OTCQB: EHVVF
 
 
 
 
 
 
 
 
Ehave, Inc.
Ehave, Inc.
Ehave is a healthcare company developing a next generation of digital solutions for stakeholders in the medical cannabis and mental health sectors. Ehave’s health informatics platform efficiently captures high-quality, objective user data.
year
2020
rev ($mm)
EBITDA ($mm)
($2.05)
EBIT ($mm)
($2.85)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: TSXV:EYC
 
 
 
 
 
 
 
 
Binovi
Binovi
Binovi is a neuro-vision enhancement platform that is designed for vision optimization and the enhancement of cognitive skills related to human performance. Binovi helps improve the lives of the 1 in 4 individuals who suffer from some form of visual impairment besides acuity loss.
year
2020
rev ($mm)
$0.42
EBITDA ($mm)
($4.63)
EBIT ($mm)
($4.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2020
rev ($mm)
$38.90
EBITDA ($mm)
$6.31
EBIT ($mm)
$5.20
Net Income ($mm)
$3.13
Employees
304
  • drill down
  • watch
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,158.07
EBITDA ($mm)
$194.47
EBIT ($mm)
$120.69
Net Income ($mm)
$74.78
Employees
8079
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2021
rev ($mm)
$221.66
EBITDA ($mm)
$54.10
EBIT ($mm)
$47.15
Net Income ($mm)
$38.31
Employees
1515
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2021
rev ($mm)
$18.63
EBITDA ($mm)
($21.80)
EBIT ($mm)
($22.10)
Net Income ($mm)
Employees
189
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: K:HLYK
 
 
 
 
 
 
 
 
HealthLynked
HealthLynked
HealthLynked provides a solution for both patient members and providers to improve healthcare through the exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare.
year
2020
rev ($mm)
$4.84
EBITDA ($mm)
($2.77)
EBIT ($mm)
($2.87)
Net Income ($mm)
Employees
37
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
DeepMatter Group Plc
DeepMatter provides an integrated software, hardware and AI-enabled platform, DigitalGlassware™, to scientists across research and process development sectors. The platform allows chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud.
year
2018
rev ($mm)
EBITDA ($mm)
($2.29)
EBIT ($mm)
($2.34)
Net Income ($mm)
Employees
25
  • drill down
  • watch
Ticker: PGND
 
 
 
 
 
 
 
 
Press Ganey Associates, Inc.
Press Ganey Associates, Inc.
Press Ganey offers an integrated suite of solutions that enables enterprise transformation across the patient journey. Delivered through a cutting-edge digital platform, Press Ganey solutions address safety, clinical excellence, patient experience, and workforce engagement.
year
2016
rev ($mm)
$344.32
EBITDA ($mm)
$104.94
EBIT ($mm)
$60.70
Net Income ($mm)
$27.26
Employees
1058
  • drill down
  • watch
Ticker: TSE:6095
 
 
 
 
 
 
 
 
MedPeer,Inc.
MedPeer,Inc.
MedPeer provides appropriate services at every stage of the clinical process physicians are involved in day-to-day clinical operation. Drug Evaluation provides detailed peer reviews of prescription drugs, and Meet the Experts allows members to consult expert physicians in specific therapeutic areas.
year
2016
rev ($mm)
$9.13
EBITDA ($mm)
$0.94
EBIT ($mm)
$0.39
Net Income ($mm)
$0.20
Employees
44
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Clarivate plc
Clarivate plc
Clarivate is a global leader in providing solutions to accelerate the lifecycle of innovation. Clarivate helps customers discover, protect and commercialize their inventions using its trusted subscription and technology-based solutions coupled with deep domain expertise.
year
2021
rev ($mm)
$1,614.03
EBITDA ($mm)
$542.18
EBIT ($mm)
$84.79
Net Income ($mm)
Employees
8568
  • drill down
  • watch
Ticker: NRCI.B
 
 
 
 
 
 
 
 
NRC Health
NRC Health
NRC Health has helped healthcare organizations illuminate and improve the moments that matter to patients, residents, physicians, nurses, and staff for 35 years.
year
2015
rev ($mm)
$101.10
EBITDA ($mm)
$29.31
EBIT ($mm)
$25.21
Net Income ($mm)
$15.78
Employees
380
  • drill down
  • watch
Ticker: NYSE:IQV
 
 
 
 
 
 
 
 
IQVIA
IQVIA
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services.
year
2018
rev ($mm)
$10,412.00
EBITDA ($mm)
$1,950.00
EBIT ($mm)
$809.00
Net Income ($mm)
$259.00
Employees
58000
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2021
rev ($mm)
$1,724.14
EBITDA ($mm)
$657.72
EBIT ($mm)
$604.18
Net Income ($mm)
$581.12
Employees
8249
  • drill down
  • watch
Ticker: ENXTPA:CGM
 
 
 
 
 
 
 
 
Cegedim
Cegedim
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases.
year
2020
rev ($mm)
$592.02
EBITDA ($mm)
$54.63
EBIT ($mm)
$53.83
Net Income ($mm)
$12.91
Employees
5171
  • drill down
  • watch